(Q46626941)

23 December 2017

title

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? (English)

1 reference

23 December 2017

author

Matthew Links

7

1 reference

23 December 2017

Kelly-Anne Phillips

10

1 reference

23 December 2017

Bettina Meiser

2

object named as

Bettina Meiser

1 reference

23 December 2017

Belinda Thewes

1

1 reference

23 December 2017

Vlatka M Duric

3

1 reference

23 December 2017

Martin R Stockler

4

1 reference

23 December 2017

Alan Taylor

5

1 reference

23 December 2017

Robin Stuart-Harris

6

1 reference

23 December 2017

Nicholas Wilcken

8

1 reference

23 December 2017

Sue Anne McLachlan

9

1 reference

23 December 2017

Jane Beith

11

1 reference

23 December 2017

Frances Boyle

12

1 reference

23 December 2017

Michael L Friedlander

13

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

Lancet Oncology Commission

published in

1 reference

23 December 2017

volume

6

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

581-588

1 reference

23 December 2017

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Life after breast cancer: understanding women's health-related quality of life and sexual functioning

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Breast irradiation postlumpectomy: development and evaluation of a decision instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Framing of outcome and probability of recurrence: breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for interferon alfa in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Someone to live for: social well-being, parenthood status, and decision-making in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Optimism, coping, and health: assessment and implications of generalized outcome expectancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Patient preference for cancer therapy: an overview of measurement approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Stability of patients' preferences for chemotherapy: the impact of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Decision-making in early breast cancer: guidelines and decision tools

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970254-0

7 January 2021

10.1016/S1470-2045(05)70254-0

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017